Establishment Labs (ESTA) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 6, 2026

Source: earnings call transcript

Establishment Labs delivered a strong Q2 FY26, driven by exceptional U.S. market penetration and the rapidly expanding minimally invasive platform. The company raised its full-year revenue guidance and is on track to become free cash flow positive in H2 2026, demonstrating increasing operating leverage and financial discipline while continuing to invest in its innovation pipeline.

You’re reading a preview. Opening the full call uses 1 concall credit.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.